Skip to main content

Salveen Richner

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Salveen Richner

Salveen Richner is recorded as Analyst at Goldman Sachs. Salveen Richner has spoken on 1 earnings call across 1 company, most recently for Vertex Pharmaceuticals Inc on February 12, 2026. The companies whose calls Salveen Richner spoke on are classified in the Healthcare sector.

Salveen Richner on recent calls

“With regard to the guidance here, is there any way you could help us understand what's baked into the guide for the CF component relative to Aleutrec and Trikafta?”
Analyst — Goldman Sachs, Vertex Pharmaceuticals Inc / Ma Q4 FY2025 Earnings Call ·

Affiliation history

  • Goldman Sachs

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity